Company: OSRH
Filing Date: 2025-08-19
Form Type: PRE 14A
Source: 0001213900-25-078140
Chunk: 19

Company: OSR Holdings, Inc.
Filing Date: 2025-08-19
Form: PRE 14A
Chunk 19
---
 firm of Jacob, Medinger & Finnegan, LLP (“JMF”)
from July 1992 until May 2016, when JMF merged with GM. From 1990 to 1992, Mr. Whang was an associate attorney with Cadwalader Wickersham &
Taft. During his career as an attorney, Mr. Whang represented major international companies in product liability litigation and regulatory
risk management domestically and internationally (Europe and Korea). His language capabilities include Korean, Spanish, French and Japanese
(conversational). Mr. Whang earned a BA in Government from Dartmouth College in 1986, a JD from Cornell Law School in 1989, and an
LLM in International and Comparative Law (with Distinction) from Georgetown Law Center in 1990. We believe Mr. Whang is well qualified
to serve as Chief Legal Officer and Secretary of the Company because of his varied and extensive legal experience.

Dr. Alcide Barberishas been a Director of the
Company as of the Closing of the Business Combination. He is a biotech entrepreneur, Board Member and Executive with over 25 years
of management experience in the biotechnology industry, and scientific experience in the private and public research sectors. He is currently
CEO & Director of Mabylon AG (since 2017). Before joining Mabylon, he was CEO & President of Humabs BioMed, now a subsidiary
of VIR Biotechnology (2013-2016). His career has included senior positions at entrepreneurial startups (Co-Founder of ESBATech AG
(1998) and Oncalis AG (2006) and senior Executive Management, R&D Management and Business Development positions. He has been member
of the Board of Directors of ESBATech (now a Novartis company, 1998-2004), Oncalis (2006-2012) and EffRx Pharmaceuticals (2016-2023),
and he is currently (since March 2023) on the Board of Directors of Ontrack Biomedical. From 2016 through 2021 he was also Coordinator
of the Startup Promotion Center of the University of Svizzera Italiana in Lugano, Switzerland. Dr. Barberis earned a PhD in Molecular
Biology and Biochemistry from the University of Zürich (1988). Dr. Barberis is well qualified to serve as a Director because
of his extensive management and leadership experience in the biotech industry, startup companies, and in